We further provided novel insight into the clinical relevance of HANR, determining that it was significantly associated with tumor size, depth of invasion, and more advanced TNM stage, indicating that HANR may be positively associated with CRC progression in patients. The gene discussed is RPL13AP20; the disease is neoplasm.